![Antoine Yver](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Antoine Yver
Director/Board Member at
SANOFI
Profile
Antoine Yver currently works at Sanofi, as Independent Director from 2022, Spotlight Therapeutics, Inc., as Director from 2022, and Stipple Bio Inc., as Director.
Dr. Yver also formerly worked at Centessa Pharmaceuticals Plc, as Executive Vice President & Chairman-Development from 2022 to 2024, Aventis SA, as Senior Director-Clinical Research from 1990 to 2005, Schering-Plough SAS, as Executive Director-Oncology from 2006 to 2009, Johnson & Johnson Medical SAS, as Senior Director-Oncology from 2005 to 2006, AstraZeneca PLC, as Head-Global Medicines Development from 2015 to 2016, and Daiichi Sankyo Co., Ltd., as EVP, Global Head-Oncology Research and Development from 2016 to 2021.
Dr. Yver received his undergraduate degree and doctorate degree from Université Paris-Saclay.
Antoine Yver active positions
| Companies | Position | Start |
|---|---|---|
| SANOFI | Director/Board Member | 2022-05-02 |
Spotlight Therapeutics, Inc.
 Spotlight Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Develops gene editing therapeutics | Director/Board Member | 2022-07-03 |
Stipple Bio Inc.
 Stipple Bio Inc. BiotechnologyHealth Technology Operates as biotechnology company | Director/Board Member | - |
Former positions of Antoine Yver
| Companies | Position | End |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | 2022-03-06 |
| DAIICHI SANKYO COMPANY, LIMITED | Corporate Officer/Principal | 2021-03-31 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 2015-12-31 |
Schering-Plough SAS
 Schering-Plough SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 2008-12-31 |
Johnson & Johnson Medical SAS
 Johnson & Johnson Medical SAS Medical DistributorsDistribution Services Wholesales pharmaceutical products | Corporate Officer/Principal | 2005-12-31 |
Training of Antoine Yver
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
59
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aventis SA
 Aventis SA Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and vaccines for preventative medicine | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Daiichi Sankyo Co., Ltd.
 Daiichi Sankyo Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the manufacture and sale of pharmaceutical products | Health Technology |
Schering-Plough SAS
Schering-Plough SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Spotlight Therapeutics, Inc.
Spotlight Therapeutics, Inc. Pharmaceuticals: GenericHealth Technology Develops gene editing therapeutics | Health Technology |
Johnson & Johnson Medical SAS
Johnson & Johnson Medical SAS Medical DistributorsDistribution Services Wholesales pharmaceutical products | Distribution Services |
Université Paris-Saclay
 Université Paris-Saclay Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centessa Pharmaceuticals Plc
 Centessa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that researches and develops medicines for neurological, neurodegenerative and neuropsychiatric disorders | Health Technology |
Stipple Bio Inc.
Stipple Bio Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
- Stock Market
- Insiders
- Antoine Yver
